Iovance Biotherapeutics Stock Forecast - Day Median Price
| IOVA Stock | USD 9.32 0.08 0.85% |
Iovance Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Iovance Biotherapeutics stock prices and determine the direction of Iovance Biotherapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Iovance Biotherapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Iovance |
| Previous Day Median Price | Day Median Price | Trend |
| 8.4 | 9.3 |
| Check Iovance Biotherapeutics Volatility | Backtest Iovance Biotherapeutics | Trend Details |
Iovance Biotherapeutics Trading Date Momentum
| On November 26 2024 Iovance Biotherapeutics was traded for 9.12 at the closing time. The top price for the day was 9.42 and the lowest listed price was 9.07 . The trading volume for the day was 4.4 M. The trading history from November 26, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.62% . The trading delta at closing time against the current closing price is 1.51% . |
The median price is the midpoint of the trading periods range.
| Compare Iovance Biotherapeutics to competition |
Other Forecasting Options for Iovance Biotherapeutics
For every potential investor in Iovance, whether a beginner or expert, Iovance Biotherapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Iovance Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Iovance. Basic forecasting techniques help filter out the noise by identifying Iovance Biotherapeutics' price trends.Iovance Biotherapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Iovance Biotherapeutics stock to make a market-neutral strategy. Peer analysis of Iovance Biotherapeutics could also be used in its relative valuation, which is a method of valuing Iovance Biotherapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Iovance Biotherapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Iovance Biotherapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Iovance Biotherapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Iovance Biotherapeutics Market Strength Events
Market strength indicators help investors to evaluate how Iovance Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Iovance Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Iovance Biotherapeutics stock market strength indicators, traders can identify Iovance Biotherapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 96282.92 | |||
| Daily Balance Of Power | (0.25) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 9.36 | |||
| Day Typical Price | 9.35 | |||
| Price Action Indicator | (0.08) | |||
| Period Momentum Indicator | (0.08) | |||
| Relative Strength Index | 47.48 |
Iovance Biotherapeutics Risk Indicators
The analysis of Iovance Biotherapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Iovance Biotherapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting iovance stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.31 | |||
| Standard Deviation | 4.35 | |||
| Variance | 18.91 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Iovance Biotherapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Iovance Biotherapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Iovance Biotherapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Iovance Biotherapeutics Stock:Check out Historical Fundamental Analysis of Iovance Biotherapeutics to cross-verify your projections. For information on how to trade Iovance Stock refer to our How to Trade Iovance Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iovance Biotherapeutics. If investors know Iovance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Iovance Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.48) | Revenue Per Share 0.327 | Quarterly Revenue Growth 123.851 | Return On Assets (0.29) | Return On Equity (0.57) |
The market value of Iovance Biotherapeutics is measured differently than its book value, which is the value of Iovance that is recorded on the company's balance sheet. Investors also form their own opinion of Iovance Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Iovance Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Iovance Biotherapeutics' market value can be influenced by many factors that don't directly affect Iovance Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Iovance Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Iovance Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iovance Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.